Skip to main content

Psychotherapy

The use of MDMA-assisted psychotherapy for the treatment of PTSD could receive final approval by the FDA by 2022, Rick Doblin, PhD, of the Multidisciplinary Association for Psychedelic Studies told Psych Congress 2020 preconference attendees.
Psych Congress cochair Charles Raison, MD, a leading researcher in the field of immune-brain interactions, explains how increased inflammation may affect response to psychotherapy.
Perspectives
As psychotherapy continues to evolve, the challenge now is to rebrand and reposition the powerful healthcare resource it has become.
Perspectives
Our field can hardly rescue primary care, but we can help it regain its proud tradition by reinforcing the importance of a comprehensive focus on health and illness.
Psychosocial interventions are reliably associated with improved immunity and appear to be a feasible way to improve immune-related health, according to a systematic review and meta-analysis in JAMA Psychiatry.
Back to Top